News
News from us and our partners
News
Crossover
News
News
Industrial Biotech
News
Capital
News
Digital Medicine
News
Tags
Topics
0 results
- News
Tenpoint Therapeutics Ltd. and Visus Therapeutics, Inc. join forces, building the next era of best-and first-in-class ophthalmic medicines
- News
Noema Pharma extends Series B financing round, closing at CHF130 Million ($147 Million)
- News
ProQR Therapeutics announces $8.1 million in new funding from Rett Syndrome Research Trust to expand RNA editing collaboration
- News
ProQR appoints Peter A. Beal, PhD, as Chief ADAR Scientist
- News
Muna Therapeutics Announces Strategic Alliance with GSK to Accelerate Development of Novel Treatments for Alzheimer’s Disease
- News
AAVantgarde Bio announces FDA Orphan Drug Designation for AAVB-081 for the treatment of Usher Syndrome type 1B Retinitis Pigmentosa
- News
Handbook for impact accountability in VC developed by coalition of impact-driven funds
- Feature
Impact accountability in venture capital: A ready reference for practitioners
- News
Women's Health Company Freya Biosciences Announces Key $10.4 Million Strategic Investment
- News
Cure51 Launches NHS-Approved Study With Cambridge University Hospitals and Seven Other Leading UK Oncology Institutions to Unlock Cancer Survival Secrets
- News
BrightHeart Secures FDA Clearance for First AI Software Revolutionizing Prenatal Fetal Heart Ultrasound Evaluations
- News
Elicit Plant announces €45 Million Investment Round to Accelerate Global Expansion
- News
TechBio startup Cure51 selects 10x Genomics Visium HD for new drug discovery initiative
- News
Noema Pharma announces first patients dosed in Phase 2b study with Gemlapodect (NOE-105), a first-in-class investigational therapy for Tourette Syndrome
- News
AAVantgarde Founder and CSO is elected as President of the European Society of Gene and Cell Therapy (ESGCT)